Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesC14-A1 is an ionizable cationic lipid that has been used in the generation of lipid nanoparticles (LNPs).1 LNPs containing C14-A1 and encapsulating mRNA encoding forkhead box protein P3 (FOXP3) increase FOXP3 levels in primary human T cells. LNPs containing C14-A1 and encapsulating mRNA encoding FOXP3 also reduce the proliferation of primary human CD4+/CD8+ T cells, as well increase TGF-β1 and decrease IL-10 secretion from CD4+/CD8+ T cells.
WARNING This product is not for human or veterinary use.
1. mRNA lipid nanoparticles for ex vivo engineering of immunosuppressive T cells for autoimmunity therapies. Nano Lett. 23(22), 10179-10188 (2023).